Europe PMC
open access
Predicting resistance to fluoroquinolones among patients with rifampicin-resistant tuberculosis: A cross-country validation study
Background Fluoroquinolones (FQs) are a cornerstone of most all-oral, shorter regimens endorsed by the World Health Organization for the treatment of rifampicin-resistant or multidrug-resistant tuberculosis (RR/MDR-TB). Knowledge of resistance to FQs can help guide regimen selection at the p
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Development of novel bioanalytical assays and an objective adherence measure of key second-line tuberculosis drugs#666629
- Global and regional trends in multidrug- or rifampicin-resistant tuberculosis, 2000-2024 with forecasts to 2030: a systematic review and meta-analysis.#258430
- Frequency of fluoroquinolone resistance in Mycobacterium tuberculosis in Southeast Spain [Frecuencia de la resistencia a fluoroquinolonas en Mycobacterium tuberculosis en Elche (Alicante)]#935768
- TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment#839951
- Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis#844972
Record · ID 1015763
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive